Global Health IPO
Global Health IPO is listed on BSE and NSE, priced at ₹319–₹336 per share. The stock debuted at ₹401, delivering a listing gain of 19.3%. The IPO had a lot size of ₹44 shares and a minimum investment of ₹14,784.
Global Health Limited IPO
- IPO Dates
- Nov 3, 2022 – Nov 7, 2022
- Price band
- ₹319-336 per equity share
- Minimum Investment
- ₹14,784
- Issue size
- Approx 2,205.57 Cr. + Fresh : ₹500 Cr + OFS : 50,761,000 Shares
- Lot size
- 44
- Allotment Date
- Nov 11, 2022
- Listing
- Nov 16, 2022
- Listing At
- BSE, NSE
IPO timeline
-
Nov 3, 2022
Open Date
Completed
-
Nov 7, 2022
Close Date
Completed
-
Nov 11, 2022
Allotment Date
Completed
-
Nov 16, 2022
Listing Date
Completed
Price Summary
- Last closing
- 1,210.30 (260.21%)
- 52 week high
- 1,456.50
- 52 week low
- 956.00
- Last update
Global Health IPO Essentials
Global Health IPO Details
Global Health IPO is priced at ₹319-336 per share with a total issue size of Approx 2,205.57 Cr. + Fresh : ₹500 Cr + OFS : 50,761,000 Shares. The IPO has a lot size of 44 shares and is listed on BSE and NSE.
- Issue price
- ₹319-336 per equity share
- Lot size
- 44 shares
- Face value
- ₹2 Per Equity Share
- Issue size
- Approx 2,205.57 Cr. + Fresh : ₹500 Cr + OFS : 50,761,000 Shares
- Listing at
- BSE, NSE
- List price
- 401.0(NSE)
- Listing date
- Registrar
- KFin Technologies Limited
- Lead manager
-
Kotak Mahindra Capital Company Limited, Credit Suisse Securities (India) Private Limited, Jefferies India Private Limited, JM Financial Consultants Private Limited
Global Health IPO Analytics
Global Health IPO category-wise subscription trends show day-wise participation across QIB, NII, and retail investors.
Global Health IPO Subscription Status
Global Health IPO subscription status shows demand across retail, NII, and QIB categories, helping investors understand overall participation trends.
The IPO subscription status indicates investor demand across categories.
| As on | QIB |
NII
bHNI
sHNI
|
Retail | Total |
|---|---|---|---|---|
| Shares Offered / Reserved | 5,956,362 |
4,625,749
3,083,832
1,541,917
|
10,793,414 | 21,375,525 |
|
Day 1
03-11-22 05:00 PM
|
0.54 x |
0.18x
0.22x
0.11x
|
0.12 x | 0.26 x |
|
Day 2
04-11-22 05:00 PM
|
0.56 x |
0.96x
1.30x
0.30x
|
0.25 x | 0.49 x |
|
Day 3
07-11-22 05:00 PM
|
28.64 x |
4.02x
5.16x
1.73x
|
0.88 x | 9.58 x |
Global Health Valuations
Earnings
- EPS (Post IPO)
- ₹7.78/-
Returns
- RoNW
- 12.14%
Global Health Financials( In Crs.)
| 30-Jun-22 | 31-Mar-22 | 31-Mar-21 | 31-Mar-20 | |
|---|---|---|---|---|
| Assets | 3221.94 | 3145.52 | 2694.1 | 2666.29 |
| Revenue | 626.54 | 2205.82 | 1478.16 | 1544.27 |
| Profit After Tax | 58.71 | 196.2 | 28.8 | 36.33 |
Global Health Company & Offer Insights
About Global Health
Global Health Limited is one of the largest private multi-speciality tertiary care providers operating in the North and East regions of India. The company has key specialities in cardiology and cardiac science, neurosciences, oncology, digestive and hepatobiliary sciences, orthopaedics, liver transplant, and kidney and urology.
Global Health Limited have a network of four hospitals currently in operation (Gurugram, Indore, Ranchi and Lucknow) under the "Medanta" brand. The company established "The Medanta Institutional Tissue Repository" in 2017 to promote biomarker and other tissue-based research.
In Fiscals 2020, 2021 and 2022 and the three months ended June 30, 2021 and 2022, the company generated income from healthcare services of Rs. 14,805.71 million, Rs. 14,178.41 million, Rs. 21,003.95 million, Rs. 4,732.10 million and Rs. 5,960.89 226 million, respectively, and had EBITDA of Rs. 2,304.54 million, Rs. 2,228.52 million, Rs. 4,897.57 million, Rs. 1,057.69 million and Rs. 1,416.46 million, respectively.
As of June 30, 2022, the company provide healthcare services in over 30 medical specialities and engage over 1,300 doctors led by experienced department heads, spanning an area of 4.7 million sq. ft., the operational hospitals have 2,467 installed beds.
Global Health Promoter(s)
Dr. Naresh Trehan are the company's promoters of Global Health.
Global Health IPO Issue Objectives
- •
- Repayment/prepayment of borrowings, in full or part, of the Subsidiaries, GHPPL and MHPL.
- •
- General corporate purposes.
Global Health IPO - Anchor Investors
Medanta mobilises Rs 661 crore via anchor book ahead of IPO.
Marquee investors participated in the offer included the Government of Singapore, Marquee investors participated in the offer included the Government of Singapore, Monetary Authority of Singapore, Nomura Trust, Stichting Depositary APG Emerging Markets Equity Pool, Ontario Teachers' Pension Plan Board, Polar Capital Funds Plc, Government Pension Fund Global, Cohesion MK Best Ideas, and Affin Hwang INR Flexi Fund.
Domestic investors such as HDFC Mutual Fund, SBI Mutual Fund, ICICI Prudential, Axis Mutual Fund, Nippon Life, SBI Life Insurance, Edelweiss, Max Life Insurance, Motilal Oswal Mutual Fund, Aditya Birla Sun Life, HDFC Life Insurance, Canara Robeco Mutual Fund, and L&T Mutual Fund also invested in the company via anchor book.
Contact Information
Frequently Asked Questions
Click any question to reveal the answer
Global Health IPO is a book-built IPO worth ₹Approx 2,205.57 Cr. + Fresh : ₹500 Cr + OFS : 50,761,000 Shares. The price band is ₹319–₹336 per share. The IPO opens on Nov 3, 2022 and closes on Nov 7, 2022. It will be listed on BSE and NSE. KFin Technologies Limited is the registrar.
The price band of Global Health IPO is ₹319 to ₹336 per share.
The lot size of Global Health IPO is 44 shares.
The minimum investment for Global Health IPO is approximately ₹14,784 based on the upper price band .
Global Health IPO opens on Nov 3, 2022 and closes on Nov 7, 2022.
The allotment date of Global Health IPO is Nov 11, 2022.
Global Health IPO is expected to be listed on Nov 16, 2022, on BSE and NSE .
Global Health IPO listed on Nov 16, 2022. It was issued at ₹401.0(NSE) and is currently around ₹1210.30 as on 14-May-2026 3:30 PM, which is approximately 260.2% versus issue price. The 52-week high is ₹1,456.50.
Based on listing and post-listing performance, Global Health IPO delivered around 260.2% over issue price. Whether it was worth applying depends on your risk profile, allocation, and holding horizon.
To buy Global Health IPO shares after listing, log in to your broker app (such as Zerodha, Angel One, Groww, Upstox, ICICI Direct), search the stock symbol, place a delivery/CNC order, and confirm quantity and price.
Global Health IPO valuation snapshot: P/E N/A, EPS ₹7.78/-, P/B N/A, RoNW 12.14%, and market cap N/A.
To apply for Global Health IPO, open the IPO Ji app or website, select the IPO, choose your demat account, enter the quantity, and submit the application.
You can check the live subscription status of Global Health IPO on IPO Ji or stock exchange websites. It shows real-time demand across retail, NII, and QIB categories.
Pre-apply allows investors to submit their IPO application before the bidding period starts. The order is placed automatically when the IPO opens.
If you pre-apply for Global Health IPO, your order will be placed when the IPO bidding starts, and a UPI mandate request will be generated.
You can check Global Health IPO allotment status on the registrar or stock exchange websites using your PAN or application number after allotment. You can also check the Global Health IPO allotment status on IPO Ji for quick and easy access.